ClinicalTrials.gg
Not yet recruitingNCT07885254App-etiteUpdated Oct 21, 2026

Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise

An interventional study of MedEx Tracker and Printed dietary and resistance exercise programme in Treatment Adherence and Compliance, Resistance Exercise and Mediterranean Diet, sponsored by Liverpool John Moores University. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Liverpool John Moores University · Not applicable, Interventional, and Prevention

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Eating a Mediterranean-style diet and doing regular resistance training are both known to lower the risk of heart disease. However, most people find it hard to stick to these habits over time, and few smartphone apps support both diet and strength training together. This study tests a smartphone app called MedEx Tracker, which was developed by the research team. The app lets people record what they have eaten against a set of Mediterranean diet targets, record the weight and repetitions for each set of their resistance training, and see how they are doing through a progress screen. It also sends reminders during the day and suggests when to increase training weight. Healthy adults aged 18 to 55 will be randomly assigned to one of two groups. Both groups will be given the same Mediterranean diet targets and the same strength training programme. One group will receive this through the app; the other will receive it as a printed booklet. This means any difference between the groups should be due to the app itself rather than to different advice. Everyone will attend the laboratory before and after the four weeks for measurements and questionnaires. The main aim is to find out whether the app is usable and acceptable to participants, and whether it helps people stick to a Mediterranean-style diet and a resistance training programme. The findings will be used to decide whether the app is suitable for a larger future study.

Read the detailed description

This is a four-week, two-arm, parallel-group feasibility randomised controlled trial conducted at Liverpool John Moores University. Healthy adults aged 18 to 55 years who own a smartphone will be randomised in a 1:1 ratio to an application-supported intervention arm (APP) or a control arm (CON). Allocation will be generated by a staff member independent of the project using a computerised random number generator. Blinding of participants is not feasible given the nature of the intervention; statistical analysis will be performed by a blinded statistician.

All participants, irrespective of allocation, will receive the same printed booklet containing Mediterranean-style dietary serving targets with serving size definitions and a structured resistance exercise programme with written technique guidance and load progression criteria, and will be asked to follow these to the best of their ability throughout the four-week intervention period. Participants in the APP arm will additionally receive access to MedEx Tracker, a purpose-built cross-platform mobile application. The application supports structured daily and weekly dietary logging against the prescribed serving targets, set-level recording of resistance exercise including load and repetitions, automated load progression prompts, an inter-set rest timer, embedded exercise demonstration videos, a library of Mediterranean recipes, and a progress dashboard displaying computed daily and weekly dietary compliance. Automated reminders are delivered three times daily for diet and every alternate day for exercise. Both arms therefore receive an identical prescription, with access to the application, and the self-monitoring, progress feedback and automated reminders it provides, representing the only difference between groups.

All participants will attend the laboratory before and after the intervention period. Primary outcomes are adherence to a Mediterranean-style diet and a resistance exercise programme, and the usability, acceptability and engagement with the application. Dietary adherence will be assessed using the 14-item Mediterranean Diet Adherence Screener and resistance exercise adherence as weekly muscle-strengthening frequency using the long form of the Muscle-Strengthening Exercise Questionnaire. Usability and acceptability will be assessed using the Mobile App Usability Questionnaire and the user version of the Mobile Application Rating Scale, supplemented by a focus group at follow-up. Engagement will be derived from application-generated data, including frequency of access and completeness of dietary and resistance exercise records. Secondary outcomes include recruitment and retention rates, dietary intake derived from three-day food records, body mass and body composition.

The study is not powered to detect definitive between-group differences. Its purpose is to establish whether the application functions as an adherence support and tracking tool of sufficient quality to be used within a subsequent fully powered trial examining LDL aggregation susceptibility.

02

Conditions studied

  • Treatment Adherence and Compliance
  • Resistance Exercise
  • Mediterranean Diet
  • Healthy Volunteers

Keywords

  • mHealth
  • mobile application
  • mediterranean diet
  • resistance training
  • dietary adherence
  • exercise adherence
  • behaviour change
  • self-monitoring
  • feasibility study
03

In context

Treatment Adherence and Compliance

128 studies on the registry are indexed under Treatment Adherence and Compliance; 64 are open to participants now.

This study's planned enrollment of 30 is below the median of 86 across 107 interventional studies indexed under Treatment Adherence and Compliance.

Browse Treatment Adherence and Compliance studies →

Lead sponsor

Liverpool John Moores University is the lead sponsor of 74 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • own and use a smartphone
  • no contraindication to exercise on a pre-activity readiness questionnaire (PARQ)

Exclusion criteria

Exclusion Criteria:

  • pregnant or nursing
  • presence of a dietary allergy or food intolerance
  • adherence to a restrictive diet (keto, carnivore, vegan, vegetarian etc)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Application-supported

    Participants receive Mediterranean-style dietary serving targets and a structured resistance exercise programme as a printed booklet, together with access to the MedEx Tracker mobile application, which provides self-monitoring, progress feedback, automated reminders and load progression prompts over four weeks.

    Behavioral: MedEx Tracker · Behavioral: Printed dietary and resistance exercise programme

  • Active comparator
    Printed booklet

    Participants receive the same printed booklet containing Mediterranean-style dietary serving targets and a structured resistance exercise programme over four weeks. No application access, progress feedback or automated reminders are provided.

    Behavioral: Printed dietary and resistance exercise programme

Interventions

  • BehavioralMedEx Tracker

    MedEx Tracker is a purpose-built cross-platform smartphone application developed by the research team to support adherence to a Mediterranean-style diet and a resistance training programme. Participants record daily servings of six food groups and weekly servings of five further food groups against defined targets, with serving definitions available within the application. Resistance training is recorded at the level of individual sets, capturing the load lifted and repetitions completed, with demonstration videos, automated prompts to increase or reduce load based on previous performance, and an inter-set rest timer. A progress dashboard displays a computed daily and weekly dietary compliance percentage, sessions completed, and seven-day activity calendars. The application also provides a library of Mediterranean diet-aligned recipes and delivers automated reminders three times daily for diet and every alternate day for exercise.

  • BehavioralPrinted dietary and resistance exercise programme

    A printed booklet containing Mediterranean-style dietary serving targets with accompanying serving size definitions, and the prescribed resistance exercises with written technique guidance and load progression criteria. Participants are asked to follow the programme to the best of their ability over the four-week study period.

06

What researchers measure

Primary outcomes

  1. Mediterranean diet adherence

    Adherence measured using the 14-item Mediterranean Diet Adherence Screener (MEDAS). Total score ranges from 0 to 14, with higher scores indicating greater adherence

    Time frame: Baseline and week 4

  2. Resistance training adherence

    Weekly muscle-strengthening frequency (days per week) assessed using the long form of the Muscle-Strengthening Exercise Questionnaire (MSEQ).

    Time frame: Baseline and week 4

  3. Application usability

    Usability assessed in the intervention group using the Mobile App Usability Questionnaire (MAUQ). Higher scores indicate better usability.

    Time frame: Week 4 (end of intervention)

  4. Application quality and acceptability

    Assessed in the intervention group using the user version of the Mobile Application Rating Scale (uMARS), scored across engagement, functionality, aesthetics and information quality. Scoring is 1-5 (higher= better).

    Time frame: Week 4 (end of intervention)

  5. Engagement with the application

    Frequency of application access and completeness of dietary and resistance training records, derived from application-generated data in the intervention group.

    Time frame: Weeks 1-4, recorded continuously by the application

Secondary outcomes

  1. Dietary intake

    Energy and macronutrient intake derived from three-day food records.

    Time frame: Baseline and week 4

  2. Body mass

    In kg using calibrated scales

    Time frame: Baseline and week 4

  3. Body composition

    Fat mass and fat-free mass assessed by bioelectrical impedance analysis

    Time frame: Baseline and week 4

  4. Recruitment rate

    Number of participants randomised per month of recruitment. Also reported: * number screened * proportion of those screened who are eligible * proportion of eligible people who consent and are randomised

    Time frame: From the start of recruitment to randomisation of the final participant (up to approximately 4 months)

  5. Retention rate

    Proportion of randomised participants who attend the week-4 follow-up visit, reported overall and by arm, with reasons for withdrawal where given.

    Time frame: Baseline to week 4 (end of intervention)

07

Study locations

1 site
  • Liverpool John Moores University
    Liverpool, Merseyside L3 3AF, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available. The small sample size and single-site recruitment mean that participants could potentially be identified from combinations of demographic and anthropometric variables. Requests for data access will be considered on an individual basis by the corresponding author, subject to approval by the Liverpool John Moores University Research Ethics Committee and completion of a data sharing agreement.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07885254
Lead sponsor
Liverpool John Moores University
Responsible party
Sponsor
First posted
Oct 21, 2026
Start date
Oct 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Alexandros M Amorginos, MSc
Contact
spsaamor@ljmu.ac.uk
+447713180851
Richard P Kirwan, PhD
study director · Liverpool John Moores University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion